Immune Thrombocytopenic Purpura in Patients with COVID-19
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were...
Main Authors: | Sabine Revuz, Nathalie Vernier, Leilah Saadi, Julien Campagne, Sophie Poussing, François Maurier |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2020-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1751 |
Similar Items
-
Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient
by: Marinescu AR, et al.
Published: (2022-06-01) -
Vaginal delivery with immune thrombocytopenic purpura-induced severe thrombocytopenia
by: Yu-HsuanChen, et al.
Published: (2022-01-01) -
Disseminated tuberculosis with immune thrombocytopenic purpura
by: Rucha S Dagaonkar, et al.
Published: (2012-01-01) -
Stroke in a young adult receiving intravenous immunoglobulin therapy for immune thrombocytopenic purpura
by: Javed Iqbal Wani
Published: (2016-01-01) -
Autoimmune Thrombocytopenic Purpura in Hepatitis A Infection
by: Can Acipayam, et al.
Published: (2014-06-01)